Global Markets: Asian Stock Markets : Nikkei down 0.06%, Shanghai Composite down 0.19%, Hang Seng up 1.26%, ASX down 0.16% Commodities : Gold at $1714.90 (-0.52%), Silver at $15.01 (-1.35%), Brent Oil at $22.21 (-3.73%), WTI Oil at $10.32 (-19.25%) Rates : US 10-year yield at 0.657, UK 10-year yield at 0.304, Germany 10-year yield … Continue reading Tuesday 28th April: Asian markets mixed, WTI carnage continues
Category: Recent
Tuesday 28th April: DXY Starts the Week Lower Consequently Retesting 100.00
The pair marched higher in early European hours, though failed to sustain gains north of 1.0860 heading into US trade, resulting in price retreating to a H4 channel resistance-turned support, taken from the high 1.0990, sited just ahead of 1.08.
Monday 27th April: Asian markets gain on BoJ stimulus
Global Markets: Asian Stock Markets : Nikkei up 2.71%, Shanghai Composite up 0.25%, Hang Seng up 2.09%, ASX up 1.50% Commodities : Gold at $1738.25 (+0.15%), Silver at $15.34 (+0.47%), Brent Oil at $23.67 (-4.59%), WTI Oil at $14.70 (-13.22%) Rates : US 10-year yield at 0.618, UK 10-year yield at 0.285, Germany 10-year yield … Continue reading Monday 27th April: Asian markets gain on BoJ stimulus
Monday 27th April: Weekly Technical Outlook and Review
After a dominant showing off 1.2647 the week prior, shaped as a shooting star candlestick pattern, last week’s movement slipped to lows at 1.2247, led by an overall stronger dollar. GBP/USD now has eyes for support at 1.2200.
Friday 24th April: Asian markets lower as FT reports Gilead’s medicine to have been ineffective in China trials
Global Markets: Asian Stock Markets : Nikkei down 0.86%, Shanghai Composite down 1.06%, Hang Seng down 0.35%, ASX up 0.49% Commodities : Gold at $1750.80 (+0.31%), Silver at $15.38 (+0.17%), Brent Oil at $21.60 (+1.27%), WTI Oil at $16.73 (+1.39%) Rates : US 10-year yield at 0.593, UK 10-year yield at 0.271, Germany 10-year yield … Continue reading Friday 24th April: Asian markets lower as FT reports Gilead’s medicine to have been ineffective in China trials